Metraipolis › archive › dc_e4585b4d1e95

Clinical complete response to serplulimab plus bevacizumab and chemotherapy in MSS/KRAS-mutant metastatic sigmoid colon adenocarcinoma: a case report and… — Europe PMC PMID:42459680

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42459680
DOI
10.3389/fimmu.2026.1740803
License (as archived)
solo-consultazione
Archived
2026-10-18T14:12:17.111Z
SHA-256 of the archived text
b1989057e60f73902bef4c6620e0efb249713b7a2a4813f42c29accc95925987
Stable URL of this page
https://metraipolis.com/documento/dc_e4585b4d1e95

How to cite

Clinical complete response to serplulimab plus bevacizumab and chemotherapy in MSS/KRAS-mutant metastatic sigmoid colon adenocarcinoma: a case report and… — Europe PMC PMID:42459680 — Europe PMC (en), https://europepmc.org/article/MED/42459680 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e4585b4d1e95 (Metraipolis archive dc_e4585b4d1e95, sha256 b1989057e60f73902bef4c6620e0efb249713b7a2a4813f42c29accc95925987)
BibTeX
@misc{dce4585b4d1e95,
  title = {Clinical complete response to serplulimab plus bevacizumab and chemotherapy in MSS/KRAS-mutant metastatic sigmoid colon adenocarcinoma: a case report and… — Europe PMC PMID:42459680},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42459680},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e4585b4d1e95; sha256 b1989057e60f73902bef4c6620e0efb249713b7a2a4813f42c29accc95925987},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42459680. Agents can read the archived copy with the MCP tool read_document.